We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

AddLife AB (ALIF B) NPV B

Sell:97.90 SEK Buy:98.05 SEK Change: 0.40 SEK (0.41%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
Sell:97.90 SEK
Buy:98.05 SEK
Change: 0.40 SEK (0.41%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
Sell:97.90 SEK
Buy:98.05 SEK
Change: 0.40 SEK (0.41%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.

Contact details

Address:
Brunkebergstorg 5, Box 3145
STOCKHOLM
103 62
Sweden
Telephone:
+46 (8) 42003830
Website:
https://www.add.life/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ALIF B
ISIN:
SE0014401378
Market cap:
11.52 billion SEK
Shares in issue:
121.86 million
Sector:
Life Sciences Tools & Services
Exchange:
Stockholm Stock Exchange
Country:
Sweden
Currency:
Swedish Krona
Indices:
n/a

Key personnel

  • Fredrik Dalborg
    President, Chief Executive Officer
  • Christina Rubenhag
    Chief Financial Officer
  • Martin Almgren
    Business Area Manager - Medtech
  • Peter Simonsbacka
    Business Area Manager - Labtech

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.